Neuroendocrine colon cancer is a rare and aggressive form of cancer that starts in the cells of the colon with both nerve and ...

A phase IIa study of ABT-263 in patients with relapsed small-cell lung cancer (SCLC). Background: To compare the presenting and prognostic characteristics, cause-specific survival (CSS) rates, and ...

The world’s largest meeting on cancer research has brought promising updates on treatment and prevention for colorectal ...

Here is a colored scanning electron micrograph of colorectal cancer cells. Adenocarcinomas of the ... Finding out requires the kind of long-term studies of large populations that are expensive ...

Reflex blood-based multi-cancer early detection (MCED) test demonstrated clinically meaningful per-cancer Positive Predictive Value (PPV) and early-stage sensitivity for multiple cancers with elevated ...

Colon cancer is the third most prevalent form of cancer in the U.S., and while screening has helped detect and prevent colon ...

Colon cancer is the third most prevalent form of cancer in the U.S., and while screening has helped detect and prevent colon ...

Researchers have been working toward using the gut microbiome as a clinical target for screening for colorectal cancer. This ...

Foundational Technology to Make Cancer Cells Revert to Normal Cells? Dec. 23, 2024 — A research team has developed a groundbreaking technology that can treat colon cancer by converting cancer ...

Hecht, MD, discusses the phase 3 OrigAMI-3 trial for patients with recurrent, unresectable, or metastatic RAS/BRAF wild-type colorectal cancer.

Confirmatory analysis to determine associations between platinum-sensitivity, molecular signature of combined tumor suppressor defects and aggressive variant prostate carcinomas (AVPC). This is an ...

A panelist discusses how NCCN guidelines now include cabozantinib as a category 1 recommendation for gastrointestinal (GI) ...